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Multiple signaling pathways control every aspect of cell behavior, organ formation, and 
tissue homeostasis throughout the lifespan of any individual. This review takes an onto-
genetic view focused on the large superfamily of TGF-β/bone morphogenetic protein 
ligands to address thymus morphogenesis and function in T cell differentiation. Recent 
findings on a role of GDF11 for reversing aging-related phenotypes are also discussed.
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introduction
The adaptive immune system evolved as a complex set of defense mechanisms amplified by the speci-
ficity properties of antigen receptor-bearing B and T lymphocytes (1). Following blood trafficking 
into the thymus, bone marrow-derived lymphoid progenitors become committed to T cell lineage 
development. Within this organ, cell specialization occurs gradually in a manner that T cell develop-
ment results in the generation of conventional CD4 and CD8 αβ T cells along with natural killer T 
cell (NKT; an innate-like T cell subpopulation), regulatory T cell (Treg), and γδ T cell subsets (2). 
Classically, commitment to T cell lineage was found to rely on the Delta-class Notch ligand Delta-like 
4 (DLL4) and the interleukin-7 (IL-7) along with kit and flt3 ligands at stages usually prior to TCRβ 
chain assembling (3–6). Branching into distinct paths can be observed throughout the mainstream 
developmental pathway, from the double-negative (DN; CD4−CD8−) T cell precursors to the highly 
expanded double-positive (DP; CD4+CD8+) cells, and the resulting mature single-positive (SP; 
CD4+CD8− or CD4−CD8+) stages. Thus, at specific niches, the thymus provides to developing T cells 
signals that trigger a series of ordered events leading to cell proliferation, TCR gene rearrangements, 
and selective checkpoints along with massive cell death (7). Altogether, these events culminate in 
a proper repertoire of distinct and specialized mature thymocyte subpopulations able to emigrate 
to the periphery. In this review paper, we highlight the role of members of the large transforming 
growth factor-β (TGF-β) superfamily (Box 1) during thymic ontogeny, thymic epithelial cell (TEC) 
differentiation and function, as well as T cell maturation. Lastly, we discuss recent information on a 
possible regenerative potential of TGF-β ligands to rescue aging-related thymus atrophy.
TGF-β Signaling and Thymus Formation
Organogenesis relies on well-organized interactions between distinct germ layers and differentiating 
cell types controlled by intricate molecular hierarchies. Thymus development occurs from common 
parathyroid bilateral rudiments in the epithelial endodermal lining of the third pharyngeal pouch 
around embryonic days (E) 9.0–9.5 in mice and early week 5 in humans (Figure 2A) (41–44). As 
growth continues through E10.5 in mice and early week 6 in humans, the contact between the third 
pharyngeal pouch and the third pharyngeal cleft ectoderm determines paired organ primordia with 
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stratified epithelium and a central lumen lined by precursors of 
medullary thymic epithelial cells (mTECs). These cells are char-
acterized by the expression of both claudin-3/4 and cytokeratin-5 
(K5) (46, 47). Further development of thymic medulla also 
depends on the successful establishment of the cortical region, as 
observed in mice with arrested T cell development (48). Within 
each primordium, a dorso-rostralmost domain expressing Gcm2 
gives rise to a parathyroid gland from E9.5 in mice or as early 
as the onset of week 6 in humans, whereas a ventro-caudalmost 
domain identified by Foxn1 expression produces a thymic lobe 
from E11.25 in mice or mid-week 6 in humans (Figure 2B) (44, 
49–52). Epithelial cell proliferation fills the pharyngeal pouch 
lumen by forming cord-like structures with smaller lumina, 
similar to branching morphogenetic events in other organs 
(Figure  2C) (47). In this context, activation of Foxn1 blocks 
the respiratory development (53) and, along with subsequent 
colonization by lymphocyte precursors, seems to be responsible 
to produce a concentric medulla less densely cellular than the sur-
rounding cortex (47). Fetal liver-derived lymphocyte progenitors 
colonize the embryonic thymus from E11.5 in mice and week 8 
in humans (54, 55), whereas short-term apoptotic events around 
E12.0 disconnect the developing anlagen from the embryonic 
pharynx (41). The rudiments migrate downwards at different 
paces, gradually resolving the Gcm2- and Foxn1-restricted 
domains into two morphologically distinct structures enclosed 
by neural crest-derived mesenchyme (Figures  2C–F) (51, 56). 
Parathyroid primordia usually lag behind and move toward the 
tracheal region dorsally to the thyroid gland, whereas thymic 
rudiments move ventrally and more caudally into the thoracic 
cavity (Figures 2D,E). The thymic primordia ultimately fuse at 
the midline to produce a bi-lobed organ above the developing 
heart (Figure 2F). Unlike mice, humans exhibit superior parathy-
roid glands derived from the fourth pharyngeal pouch (Figure 2) 
(43), whereas organogenesis of the human thymus is essentially 
similar to mice both morphologically and molecularly (44). Each 
of these morphogenetic events during thymus organogenesis is 
controlled by a multitude of signals, including members of the 
TGF-β superfamily.
Thymus Specification and Thymic epithelial 
Cell Differentiation
Early production of Bmp4 by the endoderm, the surrounding 
neural crest-derived mesenchyme, and the overlying ectoderm of 
the third pharyngeal arch and cleft raised the possibility that bone 
morphogenetic protein (BMP) signals may trigger thymus and 
parathyroid formation (57). However, conditional inactivation 
of Bmp4 in both pharyngeal endoderm and mesenchyme using 
a Foxg1–Cre line had no effect in organ induction, but resulted 
in abnormal morphogenesis (see below) (58). This could be the 
result of a short-time window of 24 h necessary to establish the 
prospective thymic and parathyroid domains as observed in 
chicken embryos (59). Indeed, Patel et  al. have observed using 
a Bmp4lacZ-reporter line that the onset of Bmp4 production 
occurred at E9.5 in the ventral pharynx close to the third pouch 
entrance, but not in the pouch endoderm or mesenchyme proper 
(57). Expression in these tissues was later achieved and expanded 
to the overlying ectoderm (57). The realization that endoderm 
patterning occurs before primitive gut and pharyngeal pouch 
formation still hampers the identification of signals responsible 
for thymus specification in vivo and other members of the TGF-β 
superfamily may also be at play (60). Particularly, activin A is 
BOX 1 | Multiple roads for signaling by TGF-β superfamily members.
The TGF-β superfamily comprises TGF-β1–3, bone morphogenetic proteins 
(BMPs), growth and differentiation factors (GDFs), Nodal, activins/inhibins, 
Müllerian inhibiting substance (MIS)/anti-Müllerian hormone (AMH), and Lefty. 
These ligands were initially grouped accordingly to the functional roles obser-
ved following their original identification (8–11). As it became clear that most 
ligands play multiple functions depending on cell type, developmental stage, 
or tissue conditions, they are now classified by sequence similarity and the 
downstream pathway they activate (12). Each family member has an overall 
basic structure, in which inactive forms are produced with an N-terminal 
secretion peptide and a large propeptide domain known as latency-associated 
peptide (LAP). Cleavage of the propeptide domain by proprotein convertases 
releases a mature domain at the C-terminus, which eventually dimerizes (13). 
The propeptide domain has major regulatory roles. It influences protein stability 
and functions as chaperone during secretion, also mediating diffusion through 
interactions with the extracellular matrix and inhibiting the active peptide form 
even after cleavage (14–16).
Signaling by TGF-β superfamily members occurs through a similar 
mechanism, but operates with distinct components. Ligands bind single-pass 
transmembrane receptor serine/threonine kinases, which relay the signal for 
intracellular effectors capable of translocating into the nucleus to modulate 
gene transcription (Figure 1). More specifically, these receptors are classified 
into two structurally similar types. Ligand binding occurs only through type II 
receptors, which then recruit and phosphorylate type I receptors [e.g., Ref. (17, 
18)]. Type II receptors, such as ActRII (Acvr2a) or ActRIIB (Acvr2b), may take 
part in many distinct pathways or may be specific for a given group of ligands, 
such as AMHR2 (Amhr2) for MIS/AMH, BMPRII (Bmpr2) for most BMPs and 
Gdf9, and TβRII (Tgfbr2) for TGF-βs (19, 20). Type I receptors are also known 
as activin receptor-like kinases (ALKs) due to their sequence similarity to acti-
vin receptors (21). These receptors are usually specific to a more restricted set 
of ligands. For instance, Nodal, Gdf1, Gdf11, activins, and inhibins bind ActRII 
to recruit Alk4 (Acvr1b) and Alk7 (Acvr1c) or they bind ActRIIB to recruit either 
Alk4, Alk7, or Alk5 (Tgfbr1) (19). Together, type II and type I receptors form a 
heterotetrameric complex, in which the type I receptor further phosphorylates 
intracellular effectors of the Smad family (22). Depending on the ligand/recep-
tor complex they are responding to, receptor-activated Smads (R-Smads) can 
be subdivided into two groups: a BMP-related set gathers Smad1, Smad5, 
and Smad9 (formerly Smad8), whereas Smad2 and Smad3 are responsive 
to TGF-β-related signals (Figure  1). An N-terminal MH1 domain negatively 
regulates the MH2 domain, being indispensable for Smad translocation into 
the nucleus and DNA binding (23–25). However, these functional properties 
do not hold true for all R-Smads. In particular, Smad2 seems to interact to 
DNA only indirectly (24).
A common mediator Smad (co-Smad), or Smad4, integrates signals 
from both branches by associating with the R-Smads (Figure 1). They form 
transcriptional complexes able to translocate into the nucleus (26–28). Nuclear 
transportation of Smads depends on accessory proteins, particularly importins, 
exportins, and nucleoporins (29, 30). The presence of DNA molecules harbo-
ring Smad-binding elements favors heterodimerization between R-Smads and 
co-Smad (28). They ultimately associate with cell-type-specific transcription 
factors and co-activators to regulate a plethora of target genes (31).
Regulation of Smad activity occurs through multiple mechanisms (32). Two 
inhibitory Smads (I-Smads) impair signaling by competing with R-Smads for 
receptors or by co-Smad interaction (33). For instance, Smad6 forms stable 
interactions with type I receptors, blocking phosphorylation of Smad2 and 
Smad1, but not Smad3 (34, 35). Similarly, Smad7, the other I-Smad mem-
ber, also binds type I receptors and suppresses further phosphorylation by 
targeting them for proteasome-dependent degradation (35, 36). The available 
literature on the molecular interactions of TGF-β superfamily members is vast, 
but not in the scope of this review. Further information can be found elsewhere 
(33, 37–40).
August 2015 | Volume 6 | Article 4423
Jurberg et al. TGF-β superfamily in the thymus
Frontiers in Immunology | www.frontiersin.org
required to induce definitive endoderm prior to the differentia-
tion of third pharyngeal pouch endoderm in vitro (61). Since gene 
targeting of some superfamily ligands or their receptors results in 
embryonic lethality (62–64), new conditional mutants should be 
produced taking into consideration that gene deletion may have 
to occur earlier and at different embryonic compartments than 
previously thought.
The possibility that thymus induction depends on synergistic 
effects of TGF-β superfamily ligands with non-superfamily 
signals is a likely case (59). Endoderm-derived undifferentiated 
epithelial cells comprise a homogeneous population pheno-
typically defined as cytokeratin (K)5+K8+EpCAM+MTS24+ in 
the thymic primordium of mouse embryos at E12.0 (65). When 
a single progenitor cell labeled with enhanced yellow fluorescent 
protein (eYFP) was microinjected into an unlabeled syngeneic 
thymus rudiment with the same age, and transplanted under the 
kidney capsule, both cortical and medullary portions showed 
scattered eYFP+ TECs also positive for region-specific markers 
after 4  weeks, revealing that common bipotent progenitors are 
able to produce both epithelial lineages during embryogenesis 
(65). Recently, thymic epithelial progenitor cells (TEPCs) bearing 
stem-cell features were also identified in the thymus of adult mice 
as a MHCIIlowα6 integrinhighSca-1high subset (66). They mature in a 
highly complex stepwise process not fully understood, ultimately 
producing cortical TECs (cTECs) or mTECs (67).
Cortical TECs are sparsely distributed and may be identi-
fied as CD45−EpCAM+Ly51(CD249)+Ulex europaeus lectin 1 
(UEA-1)−K5−K8+ cells with high levels of both MHC II and the 
proteasome subunit β5t (68–71). Considering the TGF-β-related 
pathways, cells from neonatal mice express both the Acvr2a 
(ActRII) and Acvr2b (ActRIIB) genes for the common receptors, 
in addition to Acvr1 (Alk2), Bmpr1a (Alk3), and Bmpr2 (BMPRII) 
FiGURe 1 | Signaling by ligands of the TGF-β superfamily in the thymus. 
Members of the TGF-β superfamily may signal by either the TGF-β (reddish) or 
the BMP branch (bluish). Upon binding to type II serine/threonine receptors 
occurs the recruitment of type I receptors, which further phosphorylate Smad 
proteins. Whereas ActRIIA and ActRIIB may be shared between both 
pathways, TβRII and BMPRII are specific to TGF-β and BMP signaling, 
respectively. In general, Smad2 and Smad3 relay signals from the Alk4, Alk5, 
and Alk7 receptors, while Smad1, Smad5, and Smad8/9 are phosphorylated 
by Alk2, Alk3, and Alk6 receptors. However, Alk2, Alk6, and Alk7 are not 
expressed during thymocyte maturation. Modulation of gene expression occurs 
after Smad complex translocates into the nucleus and depends on the 
interaction with additional protein complexes (not shown).
for the BMP-specific receptors, and the TGF-β-specific type I 
receptors, Alk4 (Acvr1b) and Alk5 (Tgfbr1), and type II receptor 
TβRII (Tgfbr2) (71, 72). This set of receptor genes allows cTEC 
to respond to both signaling branches of the TGF-β superfamily, 
even though the BMP receptor, Bmpr1b (Alk6), and the TGF-β 
receptor, Acvr1c (Alk7), are not present. Yet, expression of subunit 
genes Inha and Inhbb for inhibins and activins, Bmp2 and Bmp4, 
and Tgfb1 and Tgfb3 makes possible the existence of an autocrine 
circuitry for thymic homeostasis, and indicate that these factors 
might influence early thymopoiesis (71, 72).
In the thymic medulla, mTECs are characterized by a 
CD45−EpCAM+Ly51−K5+K8− phenotype with variable levels of 
UEA-1, MHCII, CD80, and Aire (67). These distinct expression 
profiles seem to take part in the differentiation program in which 
MHCIIhighCD80high mature mTECs expressing Aire are respon-
sible for the production of numerous peripheral self-antigens 
in the thymus, a critical event for central tolerance (67, 73–77). 
Hence, SP cells that strongly interact with self peptides through 
MHC molecules (pMHC) arrest migration, exhibit sustained 
TCR activation, persistent high levels of cytosolic Ca2+, and early 
caspase activation, leading to macrophage-dependent phago-
cytosis (78, 79). Surprisingly, thymocyte apoptosis triggers the 
production of all three TGF-β ligands by dendritic cells (DC), 
macrophages, and TECs in the medullary region of neonate or 
adult thymuses, a phenotype that was partially impaired in Bim 
mutants (80). In addition, apoptosis-driven production of TGF-β 
signals resulted in an increased generation of thymic regulatory 
T (tTreg) cells (see below) (80). Interestingly, mTECs are the cell 
type in the thymus that express most ligand genes of the TGF-β 
superfamily and their cognate receptors – Inha and Inhbb, Bmp2, 
Bmp3, Bmp4, Bmp5, Bmp6, and Gdf6/Bmp13, Gdf3, Gdf6/Bmp13, 
Gdf8/myostatin, Gdf10, Gdf11, and Gdf15, Lefty1 and Lefty2, 
FiGURe 2 | Signaling by TGF-β superfamily members during thymus 
organogenesis. Schematic representation of thymus formation at different 
stages of development. (A–C) Thymus specification viewed dorsally at the 
ventral half of the pharyngeal region. (A) The common parathyroid–thymus 
primordium arises from the third pharyngeal pouch endoderm. (B) Within each 
anlage, mTEC precursors line a central lumen surrounded by a dorso-
rostralmost domain expressing the BMP-antagonist Noggin and the 
parathyroid specific gene Gcm2 (light green), whereas the ventro-caudalmost 
domain expresses Bmp4 and the thymus-specific gene Foxn1 (blue). (C) Each 
primordium grows in size while proliferating cells fill the rudiment lumen, later 
colonized by lymphocyte precursors to produce an inner medulla. (D–F) 
Thymus migration toward the heart. The inferior parathyroid (light green) and 
the thymus (blue) primordia are gradually resolved as they migrate downwards. 
(D) TGF-β cues from the endothelium of pharyngeal blood vessels (e.g., carotid 
arteries) seem to orient thymic and parathyroid migration toward their final 
location. (e) The third pharyngeal pouch-derived thymic and the inferior 
parathyroid rudiments pass by the primordia of the superior parathyroid (dark 
green), which migrate only a short distance downward the tracheal region. (F) 
Fusion of the thymic primordia occurs at the midline just above the developing 
heart (not shown) [modified from Ref. (45)].
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Tgfb1, Tgfb2, and Tgfb3 along with Acvr2a (ActRII), and Acvr2b 
(ActRIIB), Acvr1 (Alk2), Bmpr1a (Alk3), and Bmpr2 (BMPRII) 
for BMP/growth and differentiation factor (GDF) signaling, and 
Acvr1b (Alk4) and Tgfbr1 (Alk5) for the TGF-β/Activin/Nodal 
pathway, in addition to the type III receptor gene Tdgf1 (Cripto) 
(71, 72, 81, 82).
The possibility that members of the TGF-β superfamily 
produced by mTECs may influence T cell differentiation or 
impact thymus physiology cannot be ruled out and remains to 
be thoroughly investigated. For instance, despite the previously 
identified BMP ligands in mTECs  –  Bmp3/osteogenin, Bmp5, 
Bmp6, and Bmp13 – there is no available functional information 
regarding their activities in the thymus to our knowledge. It is 
known, on the other hand, that Bmp6 exerts an antiprolifera-
tive effect in peripheral CD19+ B cells and induces apoptosis in 
CD27+ memory B cells (83). By contrast, Tgfbr2 deficiency in 
differentiating T cells increased apoptosis of TCRβhighCD4+ and 
TCRβhighCD8+ mature SP cells after anti-CD3 treatment or of 
TCRβhighOT-II T cells after antigen-dependent stimulation, thus 
revealing that TGF-β signals might be involved in thymocyte-
negative selection (84). Interestingly, loss of Tgfbr2 in TECs using 
a Foxn1–Cre mouse line resulted in an expansion of the mTEC 
compartment  –  especially MHCIIhigh cells  –  without affecting 
cTEC cellularity and the morphology of the corticomedullary 
junction (85). Indeed, other lymphocyte-derived signals than 
TGF-β ligands are known to influence mTEC maturation, a 
phenomenon that is largely known as “thymic cross-talk” (86).
Signaling by TGF-β superfamily members appears to play a 
secondary role in regulating a master regulator of thymus devel-
opment and function. Inactivation of the transcription factor 
Foxn1 results in an athymic phenotype despite the formation of 
an epithelial anlagen during embryogenesis (49, 87). Expression 
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of Foxn1 in thymic primordia is anticipated by the production 
of Bmp4 and Wnt4 in the epithelium and the adjacent mesen-
chyme of the third pharyngeal pouch from E10.5 in mice and 
from mid-week 6 in human embryos (23, 57, 88). Accordingly, 
in  vitro treatment of fetal thymic organ culture (FTOC) with 
BMP4 or overexpression of Wnt4 in a TEC cell line upregulated 
the expression of Foxn1 (88, 89). However, conditional inactiva-
tion of Bmp4 in the pharyngeal endoderm and mesenchyme 
did not affect Foxn1 expression (58), similarly to transgenic 
embryos expressing the BMP-antagonist Noggin in TECs (90). 
In turn, information on blockage of Wnt4 and its effect over the 
expression of Foxn1 is limited. In particular, Talaber et al. have 
shown that a single administration of dexamethasone caused 
the reduction of both Wnt4 and Foxn1 levels (91). Interestingly, 
conditional deletion of β-catenin in mTECs using a BK5–CreERT 
line resulted in Foxn1 downregulation (92). Altogether, the avail-
able evidence suggests that induction or maintenance of such an 
essential transcription factor in the thymic epithelia relies on an 
intricate molecular hierarchy with a key participation for BMP 
and WNT signals, which may provide some kind of redundancy 
for TEC differentiation and function.
With a great potential for translational medicine, differen-
tiation of TEPCs from mouse or human embryonic stem cells 
(ESCs) can be achieved under culture conditions by the addition 
of selected growth factors, including TGF-β superfamily ligands. 
For instance, Lai and Jin have initially reported that incubation 
with Fgf7, Bmp4, Egf, and Fgf10 produced K5+K8+EpCAM+ 
cells from mouse ESCs (93). These cells were able to further 
differentiate into medullary K5+K8− and cortical K5−K8+ TECs 
when transplanted with CD4−CD8−CD45+ thymocytes under 
the kidney capsule and sustain normal T cell maturation (93). In 
humans, an Activin A-dependent inductive stepwise process first 
differentiate ESCs into definitive endoderm (94), and later into 
SOX2+FOXA2+CDX2− anterior foregut endodermal cells by the 
concurrent inhibition of BMP and Activin/TGF-β signaling using 
Noggin and the type I receptor-specific inhibitor SB-431542, 
respectively (95). Further development into TEPC may be 
achieved by relatively similar approaches, generally modulating 
retinoic acid, canonical Wnt, and BMP level (61, 96).
Thymus Colonization by Lymphoid Precursors
Colonization of the thymic primordia occurs through intermit-
tent cell flow based on chemokine-dependent mechanisms (55, 
97–100). It begins discretely prior to organ vascularization 
with T cell-restricted progenitors that are unable to definitely 
populate the thymus (55, 97). Cell influx is transiently inter-
rupted during thymus migration to the thoracic cavity (42). 
Then, a second wave of cell colonization brings multipotent 
T cell- and NK-cell progenitors before birth (55). The most 
significant chemokines currently identified for attracting early 
T lineage progenitors (ETPs) to the developing avascularized 
thymus are CCL25 and CCL21 (98). Curiously, whereas CCL25 
is produced by both Foxn1-positive TECs and the adjacent 
parathyroid primordium, CCL21 is expressed only by Gcm2-
positive cells (99, 101). These ligands signal, respectively, 
through the CCR9 and CCR7 receptors present in CD45+ ETPs 
(102–105). However, it is still poor defined whether members 
of the TGF-β superfamily directly or indirectly influence or are 
modulated by these chemokines during thymus colonization. 
In particular, Gordon et al. observed delayed ETP homing into 
Bmp4-deficient thymic primordia at E11.5, but no significant 
differences in CCL25 expression in relation to wild-type thymus 
(58). The relationship with CCL21, other chemokines and their 
cognate receptors in the embryonic thymus, if present, remains 
to be determined. Of note, many pathological conditions and 
morphogenetic events show participation of TGF-βs, BMPs/
GDFs, and activins/inhibins in the modulation of chemokine 
production and vice versa (106–113).
Interaction of immigrating lymphocyte progenitors with 
the thymic stroma is critical for adult thymus organization, 
but not for TEC differentiation during embryonic develop-
ment. Using CD3ϵ transgenic mouse embryos, known to 
exhibit arrested T cell maturation at the triple negative (TN) 
CD3−CD4−CD8−CD44+CD25− ETP stage (114, 115), Jenkinson 
et al. have shown that K5+K8+ bipotent TEPCs normally differ-
entiate into functional K5+K8− medullary and K5−K8+ cortical 
TECs, although adult thymus in these transgenic animals exhibit 
persistent flat organization with morphologically abnormal 
cortex (115, 116). In particular, transfer of normal bone marrow 
cells into RAG2−/−; tgϵ26 chimeric mice, in which bone marrow 
cells from mice mutant for the recombination activating gene 2 
(RAG2) were previously transplanted into newborn tgϵ26 mice, 
rescued thymic organization and cellularity in the adult (48).
Thymus Migration
The subsequent migration of the thymus into the thoracic cavity 
also relies on signaling by members of the TGF-β superfamily 
and depends on neural crest cells. Despite a minor contribution 
in thymus cellularity, forced production of the BMP-antagonist 
Noggin in the caudal hindbrain prior to neural crest migration 
using B2-NC:Noggin transgenic mice culminated in thymic 
hypoplasia or aplasia later in development (117). Indeed, Bmp2 
induces Cdc42-dependent actin cytoskeleton reorganization and 
filopodia formation in neural crest cells, consequently affecting 
their subsequent migration (118). Moreover, conditional loss 
of Bmp4 in mice expressing Foxg1–Cre impaired the separation 
between correctly patterned parathyroid and thymus, which also 
exhibited a partially compromised capsule (58). Yet, based on 
observations performed for thyroid migration (119), Gordon 
and Manley have proposed that the downward migration of the 
thymus may be driven by signals from the pharyngeal blood 
vessels, more specifically the carotid arteries (Figures  2D–F) 
(42). Remarkably, mouse embryos with cardiac neural crest cells 
deficient for the type I receptor Alk5 (Tgfbr1) show defective 
cardiac outflow development, with atypical branching of carotid 
arteries and failed migration of still connected parathyroid and 
capsule-encased thymus (120). This raises the possibility that the 
directional cue for thymus migration might be Alk5 ligand (e.g., 
TGF-β1–3 or Gdf11), possibly secreted or released through the 
endothelium (Figures 2D–F). By contrast, conditional inactiva-
tion of Tgfbr2 in TECs by a Foxn1–Cre mouse line does not affect 
thymus final positioning (121). Although producing distinct 
phenotypes, each signaling branch by members of the TGF-β 
superfamily is involved in the downward migration of thymic 
FiGURe 3 | TGF-β superfamily during thymopoiesis. Levels of selected 
ligands, receptors, and Smad intracellular effectors during the differentiation of 
αβ T lymphocytes. Common receptors between the TGF-β and the BMP 
branches are colored in shades of gray, whereas components of the BMP and 
the TGF-β pathways are colored in shades of blue and red, respectively. The 
darker orange region of the scheme represents the thymic cortex, whereas 
light orange represents the thymic medulla. A thin corticomedullary region is 
represented in between the cortex and medulla. Omitted components are 
either not present during thymocyte maturation or no information is available at 
present. DN, double-negative; DP, double-positive; SP, single-positive.
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primordia and reveals a critical, but still poorly understood role 
for the neural crest-derived capsule during thymus organogen-
esis. Neural crest cells may also differentiate into endothelial cells, 
pericytes, and smooth muscle cells, and were found to persist in 
adult mice up to the onset of thymus involution (122).
Thymus Organization and Maturation of 
T Cells Under TGF-β Superfamily Signals
The adult thymus exhibits two gross anatomical regions easily 
identified by their histological staining patterns. The peripheral 
cortex harbors more immature and mostly small thymocytes, and 
is darker-stained due to a higher cell density. A corticomedul-
lary junction supplied by numerous septal blood vessels makes 
the transition between the cortex and the central medulla. This 
latter region is paler due to cell size and a lower T cell density 
(123–125). A capsule of connective tissue encases the organ. It 
consists of an outer layer rich in type I collagen and an inner 
layer of reticular fibers containing type III collagen, and projects 
type I collagen-containing septa into the parenchyma, partially 
subdividing the thymus into smaller lobules (126).
Signals from members of the TGF-β superfamily have a major 
influence on T cell differentiation and thymus homeostasis. As 
secreted molecules, they may be locally produced by thymic 
stromal cells and act over developing T cells as paracrine factors 
or be produced by the thymocytes themselves and work auto-
crinely. Alternatively, factors from the developing T cells may 
similarly operate over stromal cells to support thymus homeo-
stasis. However, thymocytes do not express most members of the 
TGF-β superfamily and the ones present vary in expression as 
cells differentiate (Figure 3). Similar changes are also found for 
receptor genes (127). Such differences in gene expression occur 
during T cell maturation, but also when comparing the same 
stage from fetal and adult thymuses (127–131). Nevertheless, pro-
vision of soluble growth factors seems to rely mostly to stromal 
cells, particularly TECs (71, 127). It is still possible that members 
of the TGF-β superfamily also act over large distances, being 
produced by other organs and reaching the thymus through the 
circulatory system (132). The importance of endocrine stimuli for 
intrathymic T cell maturation has been largely investigated (133), 
but whether a given TGF-β ligand exerts long-range effects over 
thymopoiesis remains to be properly addressed.
Changes in phosphorylation levels of Smad2/3 (pSmad2/3) 
and Smad1/5/8 (pSmad1/5/8), respectively, used as read-outs for 
the activities of TGF-β/Activin/Nodal and BMP/GDF signaling, 
follow differences in the expression of respective cognate recep-
tors as thymocytes mature (134, 135). Thymocytes differentiate 
in a stepwise process that involves the somatic rearrangement 
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of T cell receptor (TCR) genes while migrating in close contact 
with stromal cells and the extracellular matrix (ECM) through-
out thymic compartments (136, 137). In this process, a major 
group of αβ TCR-bearing T cells are produced, which ultimately 
function by recognizing peptide antigens presented by class I or 
class II major histocompatibility complexes (MHC I or MHC II, 
respectively) on the surface of host cells (138). Alternatively, a 
distinct lineage of T cells bearing γδ TCR chains develop, which 
recognize a quite unique group of molecules (139). Noteworthy, 
intrathymic lineage restriction and cell fate are determined not 
only by the type of TCR and its avidity for self-antigens but also by 
the acquisition of co-receptors that relay signals to intracellular 
effectors during T cell activation. Hence, generation of distinct 
cell types are tightly controlled as thymocyte progresses through 
thymic niches (7). Herein, we will point out some key aspects 
of the expression and influence of TGF-β superfamily signaling 
molecules on the distinct paths of thymocyte development: from 
CD4−CD8− DN T cell precursors (further subdivided in DN1 to 
DN4 stages based on the surface expression of CD44 and CD25) 
to the highly expanded immature CD4+CD8+ DP cells, and upon 
the mature CD4+CD8− or CD4−CD8+ SP cells.
DN1 to DN2 Cells
Entry of bone marrow-derived Lin−cKithighCD44+CD25− cells, 
or ETPs, into the thymus occurs through the corticomedullary 
junction. In this intermediate region, these immature cells with 
T cell–B cell–myeloid potential come into contact with K5+K8+ 
bipotent TEPCs and mature T cells (67, 124, 140). They subse-
quently move into the thymus cortex toward the subcapsular zone 
as DN cells, as defined by the lack of CD4 and CD8 co-receptors 
(7, 141). In the cortex, developing thymocytes then upregulate 
CD25 – the α chain of the IL-2 receptor – to become CD44+CD25+ 
DN2 cells, which undergo Dβ to Jβ recombination of the β-chain 
locus (142, 143). This DN1 to DN2 transition is accompanied by 
a strong downregulation of Bmpr1a (Alk3) and Bmpr2 (BMPRII) 
expression (127, 129). Most cells at this stage present high levels 
of pSmad2 along with Alk4 (Acvr1b) and ActRII (Acvr2a) on 
their cell surface, although a few cells also exhibit Alk5 (Tgfbr1) 
and TβRII (Tgfbr2) receptors (134). DN cells also express the type 
III co-receptor betaglycan/TβRIII (Tgfbr3), with highest levels 
at DN3 cells (144). Betaglycan seems to increase the binding 
strength of some ligands with their cognate receptors, therefore 
potentializing their effects (145–147). Thymocytes express no 
Bmpr1b (Alk6), Acvr1 (Alk2), and Acvr1c (Alk7) during thymo-
poiesis (127, 129). Yet, high levels of inhibin βA subunit (Inhba) 
and TGF-β1 (Tgfb1) contrast with reduced levels of the inhibin 
α subunit (Inha), Bmp2, Bmp4, and Bmp7 at the DN2 stage (81, 
82, 127, 130). When Inha mutants were used for E14.0 FTOC, a 
partial arrest at the DN2 stage impaired further T cell maturation 
(148). Likewise, antibody-dependent blocking of betaglycan in 
E14.0 FTOC resulted in a reduction of both DN2 and DP cells 
(144). By contrast, addition of TGF-β1 or TGF-β2 in E14.0 FTOC 
strongly inhibited T cell development by mainly impairing the 
differentiation of DN1 cells into DN2 (149). A slightly less strong 
impact after BMP4 treatment of E15.0–E15.5 FTOC or suspen-
sion cultures of fetal thymocytes resulted in cell cycle arrest at 
the DN1 stage without induction of apoptosis (89,  150). The 
use of BMP4-treated chimeric human–mouse FTOC produced 
similar findings (81), revealing a conserved role for Bmp4 during 
evolution. Besides, partial redundancy between BMP ligands 
also seems to occur in the thymus, since treatment of FTOC with 
BMP2, but not with BMP7, similarly affected the production of 
DP cells (150).
DN2 to DN3 Cells
Following T cell differentiation into CD44−/lowCD25+ DN3 cells, 
Vβ to DJβ recombination gives rise to the β chain of the pre-TCR 
(143). At this stage, the levels of Inha, Bmp2, and Bmp4 remain 
relatively low, Bmp7 becomes upregulated up to the CD3−CD8+ 
intermediate single-positive (ISP) stage, and expression of Inhba 
and Tgfb1 declines (82, 127, 130). Levels of Alk4 (Acvr1c), Alk5 
(Tgfbr1), and ActRII (Acvr2a) gradually reduce as thymocytes 
mature, in contrast to TβRII, which is slowly upregulated  –  at 
this stage, Alk4 and Alk5 are co-expressed (134). Expression of 
Bmpr1a (Alk3) and Bmpr2 (BMPRII) presents a small recovery 
at the DN3 and DN4 stages (127, 129). Nevertheless, conditional 
inactivation of Bmp7 in the hematopoietic lineage using a vav-
iCre line had no significant impact on T cell differentiation and 
total cell numbers, likely because endoderm-derived cTECs and 
mTECs may supply enough Bmp7 or other redundant factor for 
the mutant thymocytes (71, 82, 150). In particular, subcapsular 
cTECs, cortical DCs, and mTECs express Bmp2 and Bmp4 (71, 
81, 82). Activation of the Bmp4 pathway in stromal cells indi-
rectly impacts the DN to DP transition, as revealed by reconstitu-
tion experiments with thymocyte-depleted stroma treated with 
BMP4 or untreated stroma with BMP4-treated DN cells (89). Of 
note, although highly expressed up to the transition from DN2 
to DN3, being downregulated up to the DP stage, and sustained 
at low levels at SP subsets (127), the gene referred as Bmp1 is a 
procollagen C-proteinase involved in ventral body wall closure 
during embryogenesis. To our knowledge, there is no available 
functional information regarding its role during thymopoiesis, 
except that it was also found in cTECs and mTECs (71, 151).
DN3 to DN4 Cells
Should rearrangements result in unproductive β chains, DN3 cells 
undergo apoptosis and are phagocytized by cortical macrophages 
or DCs in a process termed β-selection (143, 152). Otherwise, 
successful recombination leads to a reduction in CD25 expres-
sion and the expansion of CD44−CD25− DN4 thymocytes (153, 
154). Both activin A and inhibin A similarly stimulate the DN3 
to DN4 transition, as revealed in FTOC from wild-type fetuses at 
E14.0. However, treatment with activin A led to higher numbers 
of mature CD24lowCD8+TCRβhigh T cells at the expense of CD4+ 
cells, in contrast to inhibin A treatment, which stimulated the 
transition from DN4 to DP cells (148).
DP Cells
Rearrangement of the TCRα chain occurs at the DP stage and 
cells move from the cortical zone toward the thymic medulla 
(143, 155). During this migration, cTECs present self peptides 
through MHC molecules (pMHC) to the TCR of intermingling 
DP thymocytes in a process known as positive selection, in which 
interactions of low-avidity drive clones to survive and continue 
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maturation (156). At the DP stage, Alk4 (Acvr1b), Alk5 (Tgfbr1), 
and ActRII (Acvr2a) reach their lowest levels, but the number 
of cells concomitantly presenting Alk5 and pSmad2 increases 
in relation to Alk4-positive cells (134). By contrast, Bmpr1a 
(Alk3) and Bmpr2 (BMPRII) are highly expressed (127, 129). 
Two members of the GDF subgroup, Gdf7 and Gdf11, seem to be 
induced in DP cells and sustained at SP stages, with CD4+ T cells 
presenting relatively higher levels than CD8+ T cells (127). Gdf7 
signals through BMP-specific receptors as Alk3 and BMPRII, 
whereas Gdf11 binds TGF-β-related receptors, as Alk4 and Alk5 
(157–159). Their roles on T cell function are largely obscure, 
if any. Mouse mutants for Gdf7 exhibit variable hydrocephalus 
and fail to produce a class of commissural neurons (160). Male 
mutants are sterile due to impaired differentiation and branching 
morphogenesis of the seminal vesicle, with no other affected 
reproductive structure (161). In turn, mutants for Gdf11 show 
homeotic transformations due to a delayed trunk to tail transi-
tion (162, 163). They die after birth because of renal defects, 
which may vary from hypoplasia to complete bilateral agenesis 
(164). Curiously, oral infection with Gram-negative bacteria, 
Aggregatibacter actinomycetemcomitans, in rats led to a chronic 
upregulation of Gdf11 expression among other cytokines in both 
peripheral CD45RA+CD4+ T cells and B cells (165). At present, 
however, little is known on the effects of GDFs over thymopoiesis.
SP Cells
Still in the cortex, differentiating thymocytes start to lose the 
expression of either CD4 or CD8 and migrate toward the medulla. 
The choice for either CD4 or CD8 SP lineage seems to occur at 
a transitional step defined as CD4+CD8low and depends on TCR 
interaction with the MHC class II or class I, respectively (166, 
167). Additionally, it also relies on the triggering of a transcrip-
tional machinery that operates distinctly for final differentiation 
(165, 166). Noteworthy, the SP cells sustain Bmpr1a (Alk3) and 
Bmpr2 (BMPRII) expression, and upregulate Alk5 (Tgfbr1) and 
TβRII (Tgfbr2), which lead to increased levels of pSmad2 (84, 127, 
129, 134). At this stage, fine-tuning of TGF-β signaling may occur 
by type III co-receptors  –  CD4+CD8− cells upregulate Tgfbr3 
(betaglycan), whereas CD4−CD8+ cells exhibit higher levels of 
Cripto (Tdgf1) (127, 144). Genetic loss of Tgfbr3 in FTOC resulted 
in decreased numbers of both DP and SP cells, probably related to 
the high rates of apoptosis in DN, DP, and CD4+ SP subsets (144). 
An apoptotic phenotype was also observed in the liver of Tgfbr3 
mutants (168). However, a functional role for Cripto during 
thymopoiesis is currently unresolved, despite its importance for 
TGF-β binding and inhibition (169). Mutants for this gene present 
a strong deleterious phenotype during gastrulation and die shortly 
afterward (170, 171). Modulation of TGF-β family members, their 
receptors, and co-receptors at the DP stage is therefore associated 
with the terminal differentiation of thymocytes.
impact of TGF-β Signals on the 
Differentiation of Thymic 
Regulatory T Cells
Regulatory T (Treg) cells have the ability to suppress autoreactive 
T cells, and they can originate from the thymus or be induced 
in the periphery (172). Thymus-derived Treg (tTreg) arise in 
the thymus from SP CD4+ T cells that escape negative selection 
during maturation by presenting TCR signals of variable affini-
ties (80, 172–174). More specifically, TCRs with high avidity for 
self-antigens trigger a new upregulation of CD25 (IL-2 receptor 
α chain) and therefore exhibit an increased responsiveness to 
IL-2, ultimately inducing the expression of the transcription 
factor forkhead box P3 (Foxp3) through a STAT5-dependent 
mechanism (175–177). Foxp3 is the critical transcription factor 
for Treg cell lineage, as its loss abolishes tTreg cells and lead to 
systemic autoimmunity and death (178, 179). Conversely, forced 
expression of Foxp3 in CD25−CD45RBhighCD4+ SP cells trans-
ferred into severe combined immunodeficiency (SCID) hosts 
suppressed exacerbated inflammation (180). Unlike previously 
thought (181), however, expression of Foxp3 in developing tTreg 
cells induced apoptosis instead of cell survival. Cell death is pre-
vented by limiting concentrations of γc-mediated survival signals 
enough to sustain only fewer than one million Foxp3+ cells (182).
Signals from members of TGF-β superfamily also play impor-
tant roles over the differentiation and survival of tTreg cells. In 
particular, conditional loss of Tgfbr1 (Alk5) in thymocytes seems 
to be involved in tTreg specification, since a Lck–Cre mouse line 
completely blocked differentiation of tTreg cells in neonatal mice, 
whereas later inactivation of Tgfbr1 by a Foxp3–Cre line produced 
no differences in tTreg numbers as compared to wild-type mice 
(80, 183). In addition, the intrathymic injection of an anti-TGF-β 
antibody suppressed Foxp3 expression in a TCR transgenic 
CD4+CD25− SP cells (80). Of note, impaired Alk5 signaling 
induced by the Lck–Cre line caused no significant impact on 
CD4+ and CD8+ SP cell numbers (183). A later increase in Treg 
cells induced in the periphery (pTreg) in these mutant mice 
relied on IL-2 signaling, since ablation of this cytokine produced 
no detectable cells in organs, such as the spleen and liver (183). 
Similarly, thymocyte deficiency of Tgfbr2 from a CD4–Cre mouse 
line resulted in reduced numbers of tTreg cells due to Bim-
dependent apoptosis likely independent of γc-signaling, without 
affecting TCR-βhighCD4+Foxp3− mature T cells in neonatal mice 
(84). Unlike Tfgbr1-mutant thymocytes, conditional deletion of 
Tgfbr2 also resulted in low numbers of pTreg cells (84). Induction 
of pTreg cells relies on the Smad3-dependent upregulation of 
Foxp3 triggered by activation of both TCR and TGF-β signal-
ing and facilitated by retinoic acid, which increased pSmad3 
accessibility to regulatory sequences of the Foxp3 promoter and 
concurrently counteracted the suppressing effects of a c-Jun 
N-terminal Kinase (JNK) inhibitor (184, 185). Genetic analyses 
of the regulatory CNS1 region of Foxp3, which contains binding 
sites for NFAT, Smad3, and RAR/RXR, revealed that tTreg cell 
development occurs independently of its activation, whereas its 
chromosomal deletion largely impaired the production of pTreg 
cells in secondary lymphoid organs (184–186). In accordance 
to the different requirements revealed for tTreg in comparison 
to pTreg populations, TGF-β1 is essential for the peripheral 
differentiation and maintenance of pTreg cells, but seems to be 
dispensable for tTreg maturation (187).
Taking into consideration the upregulation of all three TGF-
β ligands by stromal cells upon thymocyte apoptosis in the 
thymus, along with recent findings regarding mutants for distinct 
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TGF-β-specific receptors (80, 84, 183), it is possible that TGF-β 
ligands may play a redundant yet underestimated role in the 
immune system. Noteworthy, mutants for TGF-β2 and TGF-β3 
also exhibit perinatal mortality, a characteristic that complicates 
the examination of their role in adults (188–190). Although at 
first sight, the phenotypes observed in these mutants were gener-
ally non-overlapping, some particular structures showed similar 
defects between single mutants (e.g., cleft palate in either TGF-β2 
and TGF-β3 mutants) or exclusive abnormalities in compound 
mutants, such as abnormal brain vascular morphogenesis and 
impaired midline fusion along with earlier embryonic lethality in 
Tgfb1RGE;Tgfb3 and Tgfb2;Tgfb3 compound mutants, respectively 
(191, 192). However, development of tTreg was never evaluated 
in these compound mutants. An alternative explanation may con-
sider the participation of a previously unappreciated ligand of the 
TGF-β superfamily in the differentiation of tTreg cells. Whether 
this is indeed the case, this candidate ligand should probably 
signal through Alk5 and TβRII receptors to phosphorylate Smad2 
and Smad3 intracellular effectors. Thereby, likely ligands to be 
thoroughly evaluated due to their expression pattern and receptor 
affinity are Gdf11 and Gdf8/myostatin – curiously two members 
that showed redundancy in patterning the axial skeleton as 
revealed by Gdf11;Mstn double mutants. Unfortunately, examina-
tion of fetal thymus morphology and T cell differentiation using 
FTOC was not performed in these mutants (193).
Noteworthy, TGF-β signals also regulate the thymic develop-
ment of IL-17-producing cells. A subset of γδ T cells acquire 
the capacity to produce IL-17 inside the thymus via a TGF-β1-
dependent machinery, and both Tgfβ1−/− and Smad3−/− mice 
were shown to be completely devoid of IL-17-producing γδ 
T  cells (194). Additionally, NKT17 cells comprise a thymic-
derived IL-17-producing, CD1d-restricted, and glycolipid 
antigen-reactive T cell subset (195, 196). These cells express high 
levels of TβRII and depend on TGF-β signals for differentiation 
and survival within the thymus and in the periphery (197, 198).
A TGF-β Member for Thymus 
Rejuvenation?
Aging is an inherent process of living beings, normally associated 
with gradual loss of function and structure over time – accumula-
tion of reactive species, DNA damage, abnormally folded proteins, 
and telomere shortening are just some of the molecular changes 
that may be followed by increased apoptosis, cell transformation, 
or other cellular event that will ultimately lead to death (199). 
Although this negative scenario was initially thought to be 
irreversible, numerous evidences point out that at least in part 
it is possible to slow down or eventually reverses some specific 
aging phenotypes. Taking the thymus as example, aging is easily 
recognizable by a sharp decrease in cellularity of both lymphoid 
and stromal compartments, whereas the number of thymic adi-
pocytes inversely increases (200, 201). Ultimately, these thymic 
changes lead to a reduction of naïve T cells in the periphery along 
with an increase of memory T cells, which reflects in the organ-
ism ability to respond to both infection and tumorigenesis (202).
Multiple factors may trigger thymic involution, including 
the production of sex steroid hormones from puberty, increased 
calorie intake, or diminished levels of some growth factors and 
cytokines, such as fibroblast growth factor 7 (FGF7)/keratinocyte 
growth factor (KGF), insulin-like growth factor (IGF-1), growth 
hormone (GH), interleukin-7 (IL-7), and IL-22 (203). Modulation 
of each of them is able to rescue the aged thymic phenotype and 
restore the immune function at some level (204–210). However, 
some of these strategies may be inefficient, invasive, non-specific, 
or produce undesirable side effects to be used in humans (211). A 
quest for thymic rejuvenation therapies therefore faces daunting 
challenges in the clinic. Of particular interest, forced expression 
of Foxn1 was shown to effectively reprogram fibroblasts into TECs 
or regenerate fully involuted thymuses at many different experi-
mental setups, both in vitro or in vivo (212–214). In this context, 
signals that control Foxn1 expression might be used to restore the 
integrity of the thymic epithelial niche and subsequently flourish 
thymopoisesis in the elderly. In this scenario, administration of 
soluble factors, such as ligands of the TGF-β superfamily, may be 
used as regenerative drugs.
Recent findings have revealed that levels of some circulating 
factors vary with age and that heterochronic parabiosis, i.e., a sur-
gical procedure that connects the circulatory systems of animals 
with different ages, was able to reverse age-related phenotypes as 
cardiac hypertrophy (132). These authors further identified the 
TGF-β member Gdf11 as responsible for restoring cardiac func-
tion in old mice, a finding that was further expanded to other sys-
tems. In particular, daily treatment of old mice with recombinant 
GDF11 improved skeletal muscle mass and strength, as well as the 
integrity of brain vasculature and cognitive function (215, 216). 
In culture, Gdf11 promoted osteoblastogenesis while inhibiting 
adipogenesis in bone marrow-derived cells (217). Administration 
of GDF11 in endothelial progenitor cells triggered cell sprouting 
and migration, also revealing a role in the formation of blood 
vessels (218).
Whether Gdf11 or other circulating factor can be used as a 
rejuvenating cytokine for the thymus remains to be thoroughly 
assessed. Indeed, Gdf11 is expressed in the thymus of young mice 
(132), whereas the levels of its non-exclusive receptors, Alk4 and 
Alk5, vary in thymocytes and TECs, as previously discussed. Of 
note, however, therapy with Gdf11 produced some side effects 
in mice (219), and a recent study by Egerman et al. has recently 
questioned the aforementioned observations (220). Whereas 
these controversial data on Gdf11 await further investigation, 
it is noteworthy that heterochronic parabiosis did not reverse 
thymic involution, but caused atrophy with mild effects on T cell 
subpopulations of young mice and a reduction in the number of 
CD4+CD25+Foxp3+ regulatory T cells in old partners to the level 
of the young pair (221). Although a putative rejuvenating factor 
for the thymus still awaits to be determined, this controversial 
matter helps to bring the debate on the role of TGF-β superfamily 
members for the thymus function.
Concluding Remarks
Although the differentiation of T cells is mainly driven by the 
rearrangement of TCR genes, many members of the TGF-β 
superfamily exert critical roles in their stepwise progression 
during thymic migration. Historically, special attention had been 
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